A., McElwee, K
doi:10.1002/path.5056 Yang X, Qiang Q, Li N, Feng P, Wei W, Hlscher C
Monitoring requirements Qsymia requires more routine monitoring than GLP-1 medications: Monthly pregnancy tests for women of childbearing age Regular heart rate monitoring Periodic blood work for bicarbonate levels (metabolic acidosis screening) Kidney function tests Mood and cognition assessment GLP-1 medications generally require less intensive monitoring, though periodic blood work to check pancreatic enzymes and kidney function is still recommended
Semaglutide's action on the hypothalamusthe brain region controlling hunger, energy balance, and sleep-wake cyclesmeans changes in one system may ripple into another
Citation: Teichman SL, Neale A, Lawrence B, et al
Understanding these factors will be crucial for developing targeted therapies that can precisely modulate this pathway